| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 0.0 | 0.0 | 0.0 |
| Total income | 0.0 | 0.0 | 0.0 |
| Profit before exceptional items & tax | -0.3 | -0.3 | -0.1 |
| Profit before tax | -0.3 | -0.3 | -0.1 |
| Net profit | -0.3 | -0.3 | -0.1 |
| Operating margin | 0.0% | 0.0% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
BSE results filing, NSE: CITURGIBIO. Figures extracted from the filing.
Citurgia Biochemicals Ltd: key numbers
- Share price
- ₹103.45
- Market cap
- ₹1,367 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-0.74 Cr
- P/E (TTM)
- -1845.0×Sector 36.8×
- Promoter holding
- 99.36%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Citurgia Biochemicals Ltd
All →Citurgia Biochemicals Other Announcement
Citurgia Biochemicals Limited received approval from the Registrar of Companies for a one-month extension to hold its 51st Annual General Meeting by October 31, 2026.
Citurgia Biochemicals Management Change
Citurgia Biochemicals submitted the resignation letter of CS Yatendra Kumar, effective 24 July 2026. The filing rectifies a prior omission of the letter under Regulation 30 (LODR).
Citurgia Biochemicals Q1 FY27 Results: Net Loss of ₹0.1 Cr, Loss Widens
Citurgia Biochemicals Ltd reported a net loss of ₹0.1 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.1 Cr
Citurgia Biochemicals Board Meeting Date
Citurgia Biochemicals Limited will hold a board meeting on August 12, 2026, to consider and approve standalone unaudited financial results for the quarter ended June 30, 2026.
Citurgia Biochemicals Management Change
Company Secretary CS Yatendra Kumar has resigned to pursue other carrier opportunities. The resignation is effective from July 24, 2026.
Citurgia Biochemicals Financial Results
Citurgia Biochemicals reported its audited standalone financial results for the quarter and year ended March 2026. The company recorded zero revenue and a net loss.